{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:12:24Z","timestamp":1791645144014,"version":"4.3.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00417-020-04651-6","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T04:02:46Z","timestamp":1589342566000},"page":"2013-2021","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Efficacy of rituximab in patients with Graves\u2019 orbitopathy: a retrospective multicenter nationwide study"],"prefix":"10.1007","volume":"258","author":[{"given":"Jean-Baptiste","family":"Deltour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"d\u2019Assigny Flamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Ladsous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama","family":"Giovansili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Cariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Drui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Lebranchu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"key":"4651_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Baldeschi L, Boboridis K et al (2016) The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy Guidelines for the Management of Graves\u2019 Orbitopathy. Eur Thyroid J 5:9\u201326. https:\/\/doi.org\/10.1159\/000443828","journal-title":"Eur Thyroid J"},{"key":"4651_CR2","doi-asserted-by":"publisher","first-page":"5234","DOI":"10.1210\/jc.2005-0148","volume":"90","author":"GJ Kahaly","year":"2005","unstructured":"Kahaly GJ, Pitz S, Hommel G, Dittmar M (2005) Randomized, single blind trial of intravenous versus oral steroid monotherapy in graves\u2019 orbitopathy. J Clin Endocrinol Metab 90:5234\u20135240. https:\/\/doi.org\/10.1210\/jc.2005-0148","journal-title":"J Clin Endocrinol Metab"},{"key":"4651_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1089\/thy.2006.0267","volume":"17","author":"R Le Moli","year":"2007","unstructured":"Le Moli R, Baldeschi L, Saeed P et al (2007) Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in graves\u2019 ophthalmopathy. Thyroid 17:357\u2013362. https:\/\/doi.org\/10.1089\/thy.2006.0267","journal-title":"Thyroid"},{"key":"4651_CR4","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1210\/jc.2006-2388","volume":"92","author":"D El Fassi","year":"2007","unstructured":"El Fassi D, Nielsen CH, Bonnema SJ et al (2007) B lymphocyte depletion with the monoclonal antibody rituximab in graves\u2019 disease: a controlled pilot study. J Clin Endocrinol Metab 92:1769\u20131772. https:\/\/doi.org\/10.1210\/jc.2006-2388","journal-title":"J Clin Endocrinol Metab"},{"key":"4651_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ophtha.2009.05.029","volume":"117","author":"D Khanna","year":"2010","unstructured":"Khanna D, Chong KKL, Afifiyan NF et al (2010) Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy. Ophthalmology 117:133\u2013139.e2. https:\/\/doi.org\/10.1016\/j.ophtha.2009.05.029","journal-title":"Ophthalmology"},{"key":"4651_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/cen.12141","volume":"79","author":"AL Mitchell","year":"2013","unstructured":"Mitchell AL, Gan EH, Morris M et al (2013) The effect of B cell depletion therapy on anti-TSH receptor antibodies and clinical outcome in glucocorticoid-refractory graves\u2019 orbitopathy. Clin Endocrinol 79:437\u2013442. https:\/\/doi.org\/10.1111\/cen.12141","journal-title":"Clin Endocrinol"},{"key":"4651_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/IOP.0b013e3181c4dfde","volume":"26","author":"RZ Silkiss","year":"2010","unstructured":"Silkiss RZ, Reier A, Coleman M, Lauer SA (2010) Rituximab for thyroid eye disease. Ophthal Plast Reconstr Surg 26:310\u2013314. https:\/\/doi.org\/10.1097\/IOP.0b013e3181c4dfde","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"4651_CR8","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1001\/jamaophthalmol.2013.8179","volume":"132","author":"EB Suhler","year":"2014","unstructured":"Suhler EB, Lim LL, Beardsley RM et al (2014) Rituximab therapy for refractory orbital inflammation: results of a phase I\/II dose-ranging randomized clinical trial. JAMA Ophthalmol 132:572\u2013578. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.8179","journal-title":"JAMA Ophthalmol"},{"key":"4651_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.4158\/EP09385.RA","volume":"16","author":"S Madaschi","year":"2010","unstructured":"Madaschi S, Rossini A, Formenti I et al (2010) Treatment of thyroid-associated orbitopathy with rituximab--a novel therapy for an old disease: case report and literature review. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 16:677\u2013685. https:\/\/doi.org\/10.4158\/EP09385.RA","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"4651_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4274\/tjo.26780","volume":"47","author":"T \u015eim\u015fek","year":"2017","unstructured":"\u015eim\u015fek T, Y\u0131ld\u0131r\u0131m N, Efe B, Kebap\u00e7\u0131 N (2017) Rituximab treatment in a patient with active graves\u2019 Orbitopathy and psoriasis. Turk J Ophthalmol 47:42\u201346. https:\/\/doi.org\/10.4274\/tjo.26780","journal-title":"Turk J Ophthalmol"},{"key":"4651_CR11","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1210\/jc.2014-2572","volume":"100","author":"MN Stan","year":"2015","unstructured":"Stan MN, Garrity JA, Carranza Leon BG et al (2015) Randomized controlled trial of rituximab in patients with graves\u2019 orbitopathy. J Clin Endocrinol Metab 100:432\u2013441. https:\/\/doi.org\/10.1210\/jc.2014-2572","journal-title":"J Clin Endocrinol Metab"},{"key":"4651_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1210\/jc.2014-3014","volume":"100","author":"M Salvi","year":"2015","unstructured":"Salvi M, Vannucchi G, Curr\u00f2 N et al (2015) Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe graves\u2019 orbitopathy: a randomized controlled study. J Clin Endocrinol Metab 100:422\u2013431. https:\/\/doi.org\/10.1210\/jc.2014-3014","journal-title":"J Clin Endocrinol Metab"},{"key":"4651_CR13","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1530\/EJE-16-0552","volume":"176","author":"MN Stan","year":"2017","unstructured":"Stan MN, Salvi M (2017) MANAGEMENT OF ENDOCRINE DISEASE: rituximab therapy for graves\u2019 orbitopathy - lessons from randomized control trials. Eur J Endocrinol 176:R101\u2013R109. https:\/\/doi.org\/10.1530\/EJE-16-0552","journal-title":"Eur J Endocrinol"},{"key":"4651_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1365-2265.1993.tb00516.x","volume":"38","author":"P Perros","year":"1993","unstructured":"Perros P, Crombie AL, Matthews JN, Kendall-Taylor P (1993) Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clin Endocrinol 38:367\u2013372","journal-title":"Clin Endocrinol"},{"key":"4651_CR15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/jama.1993.03500040045034","volume":"269","author":"MF Prummel","year":"1993","unstructured":"Prummel MF, Wiersinga WM (1993) Smoking and risk of graves\u2019 disease. JAMA 269:479\u2013482","journal-title":"JAMA"},{"issue":"Suppl 2","key":"4651_CR16","first-page":"185","volume":"21","author":"MF Prummel","year":"1989","unstructured":"Prummel MF, Wiersinga WM, Mouritis MP, Koornneef L, Berghout A, van der Gaag R (1989) Amelioration of eye changes of graves\u2019 ophthalmopathy by achieving euthyroidism. Acta Endocrinol 21(Suppl 2):185\u2013189","journal-title":"Acta Endocrinol"},{"key":"4651_CR17","doi-asserted-by":"publisher","first-page":"632","DOI":"10.7326\/0003-4819-129-8-199810150-00010","volume":"129","author":"L Bartalena","year":"1998","unstructured":"Bartalena L, Marcocci C, Tanda ML et al (1998) Cigarette smoking and treatment outcomes in graves ophthalmopathy. Ann Intern Med 129:632\u2013635","journal-title":"Ann Intern Med"},{"key":"4651_CR18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1365-2249.2010.04191.x","volume":"161","author":"G Vannucchi","year":"2010","unstructured":"Vannucchi G, Campi I, Bonomi M et al (2010) Rituximab treatment in patients with active graves\u2019 orbitopathy: effects on proinflammatory and humoral immune reactions. Clin Exp Immunol 161:436\u2013443. https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04191.x","journal-title":"Clin Exp Immunol"},{"key":"4651_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1001\/archopthalmol.2011.1215","volume":"130","author":"M Salvi","year":"2012","unstructured":"Salvi M, Vannucchi G, Curr\u00f2 N et al (2012) Small dose of rituximab for graves orbitopathy: new insights into the mechanism of action. Arch Ophthalmol Chic Ill 1960 130:122\u2013124. https:\/\/doi.org\/10.1001\/archopthalmol.2011.1215","journal-title":"Arch Ophthalmol Chic Ill 1960"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-04651-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-020-04651-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-04651-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T23:30:28Z","timestamp":1620862228000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-020-04651-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["4651"],"URL":"https:\/\/doi.org\/10.1007\/s00417-020-04651-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,13]]},"assertion":[{"value":"6 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed were in accordance with the 1964 Helsinki Declaration and its later amendments.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study protocol was accepted by the local ethics committee (GNEDS: \u201c<i>Groupe Nantais d\u2019Ethique dans le Domaine de la Sant\u00e9\u201d<\/i>). Informed consent was not required for this non-interventional retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of interest"}}]}}